Centralization of symptoms and lumbar range of motion in patients with low back pain.

This quasi-experimental repeated measures study examined the relationship between centralization of symptoms and lumbar flexion and extension range of motion (ROM) in patients with low back pain. Rapid and lasting changes in lumbar ROM have been noted with centralization of symptoms. However, no study has objectively measured the changes in lumbar ROM occurring with centralization. Forty-two adult subjects (mean age, 45.68 years; SD=15.76 years) with low back pain and associated lower extremity symptoms were followed by McKenzie trained physical therapists. Subjects' lumbar ROM was measured at the beginning and end of each patient visit by using double inclinometers, and pain location was documented. Subjects were grouped as 1) centralized, 2) centralizing, or 3) noncentralized for comparisons of symptom and ROM changes. Data were analyzed by using multivariate analysis of variance and one-way analysis of variance. Significance was set at 0.05. A significant difference was found between initial and final mean extension ROM in the centralized and centralizing groups (p=0.003). No significant difference was found in the noncentralized group (p<0.05). Subjects (n=23) who demonstrated a change in pain location during the initial visit also showed a significant (p<0.001) change in extension ROM, whereas patients with no change in pain location (n=19) did not (p=0.848). Lumbar extension ROM increased as centralization occurred.

Testosterone and growth hormone normalization: a retrospective study of health outcomes.

BACKGROUND: Age-related declines in testosterone and growth hormone (GH) are associated with increased adiposity and decreases in lean mass and bone mineral density (BMD). A long-term retrospective study examined the effects of testosterone and/or GH supplementation on body composition and quality of life (QoL). METHODS: A database survey assessed the records of 91 men and 97 women (ages 25-82) in treatment groups based on their hormonal status: dehydroepiandrosterone but no hormonal supplementation (control); testosterone only (Tes); GH only (GH); and testosterone plus GH (Tes+GH). Pre-and post-treatment assessments recorded changes in fat and lean mass, BMD, and QoL. RESULTS: After an average of 3 years of treatment, weight decreased in women in the control and Tes+GH groups but remained stable in men in all groups. Tes and Tes+GH produced statistically significant increases in lean mass, reductions in fat mass, and improvements in BMD in both sexes; GH produced similar changes in women. QoL and mood improved in all groups. Treatments were generally safe and well tolerated. CONCLUSIONS: In this retrospective survey, treatment with testosterone and/or GH was associated with favorable effects in men and women across a wide age range.

Patient and physician attitudes to using medications with religiously forbidden ingredients.

BACKGROUND: Over 1000 medications contain pork- and/or beef-derived gelatin and stearic acid as inert ingredients. Use of these medications in patients with religious beliefs against consumption of these ingredients might constitute an ethical conflict. OBJECTIVE: To assess patients' and physicians' attitudes about using medications with religiously prohibited ingredients derived from pork and/or beef. METHODS: In this pilot study, 100 patients and 100 physicians completed a survey designed to assess their knowledge and opinion on using medications that might contain inert ingredients derived from animals whose consumption offends followers of certain religions. RESULTS: Of the 100 patients surveyed, most (84%) reported that they were not aware that several medications contained ingredients derived from pork and/or beef. About 63% of the patients wanted their physicians, and 35% of the patients wanted their non-physician healthcare providers (pharmacists, nurses), to inform them when using such medications. Thirteen percent of the patients shared religious reasons for not consuming pork and/or beef products. Approximately 70% of physicians were unaware that several medications contain ingredients that might be against their patients' religion, and most (70%) thought that it was important to inform their patients if such drugs were prescribed. CONCLUSIONS: This pilot study suggests that both patients and physicians think that patients should be informed whenever medications that contain pork- and/or beef-derived products are prescribed. The use of medications with these ingredients is an ethical issue. Informing patients about this issue promotes respect for their religious beliefs and may promote therapeutic alliance; therefore, this might have public health implications and needs further research.